Company
Headquarters: Kwun Tong, Hong Kong
Employees: 62
HK$199.0 Million
HKD as of Jan. 1, 2024
US$25.5 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China. It operates through three segments: Pharmaceutical Products, Finance Leasing, Other General Trading, and Genetic Testing and Molecular Diagnostic Services. The company provides branded prescription products, as well as non-prescription Western medicine and proprietary Chinese medicine products, including proprietary Chinese medicine injections. It offers products primarily in the therapeutic areas of respiratory, cardiovascular, gastroenterology, and infectious diseases, as well as cancer. The company also engages in the sale of pharmaceutical related software and provision of consultancy services; finance leasing; and the trading of goods. The company was formerly known as Wuyi International Pharmaceutical Company Limited and changed its name to Sanai Health Industry Group Company Limited in November 2017. Sanai Health Industry Group Company Limited was incorporated in 2006 and is based in Kwun Tong, Hong Kong.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Sanai Health Industry Group Company Ltd has the following listings and related stock indices.
Stock: HKEX: 1889 wb_incandescent